Clinical Trials Browser

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003338 2021-08-16

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Phase 2/3 Unknown

60 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04653493 2021-03-19

CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

Phase 1 Unknown

22 enrolled

Lymphoid

Burkitt Lymphoma

NCT03156101 2021-02-04

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects

Phase 1/2 Unknown

24 enrolled

Lymphoid

Burkitt Lymphoma

NCT03265106 2021-02-04

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects

Phase 1/2 Unknown

20 enrolled

Lymphoid

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04204161 2021-02-04

A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma

Phase 1 Unknown

30 enrolled

Lymphoid

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04626726 2020-11-13

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Phase EARLY_PHASE1 Unknown

50 enrolled

Lymphoid

Burkitt Lymphoma

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Phase 1/2 Unknown

73 enrolled

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT04191941 2019-12-10

Treatment of Hematological Malignancy With Novel CAR-T Cells.

Phase EARLY_PHASE1 Unknown

9 enrolled

LymphoidPlasma cell

Burkitt Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

NCT04184414 2019-12-03

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Phase EARLY_PHASE1 Unknown

10 enrolled

Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Mantle-Cell

NCT03000335 2019-02-04

Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk

Unknown

65 enrolled

Lymphoid

Burkitt Lymphoma, Recurrence

NCT03671460 2018-09-14

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

Phase 1 Unknown

18 enrolled

Lymphoid

Burkitt Lymphoma

NCT03574168 2018-06-29

CD19-CAR-T Cells in Patients With R/R B-ALL

Phase 1 Unknown

40 enrolled

Lymphoid

Burkitt Lymphoma

NCT03281551 2017-09-15

Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma

Phase 1 Unknown

50 enrolled

Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

Clinical Trials

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects

A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Treatment of Hematological Malignancy With Novel CAR-T Cells.

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

CD19-CAR-T Cells in Patients With R/R B-ALL

Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma